Abstract: A premixed underground ventilated henhouse includes a gable, a sidewall, a roof and a floor. An inner chamber is further provided in the middle of the henhouse. A partition is hermetically provided between the sidewall and an inner wall. An air inlet plate is provided between the two inner walls. A plurality of fans and a plurality of air inlet windows are uniformly provided on an inner roof. A plurality of wet curtains and an air vent are provided on the sidewall. Air outlet slots are uniformly provided on the inner wall. An underground exhaust bunker is provided under the floor. A vent pipe and a fan are provided on one side of the underground exhaust bunker. An air outlet is provided at an upper end of the vent pipe.

Abstract: A MR wireless receiving coil device may include transmitters and receivers, the number of the receivers being equal to or greater than the number of the transmitters; each transmitter comprises: a coil group, an ADC group, two baseband low-pass filters, and an IQ modulation transmitter, wherein the coil group is connected to the ADC group, the ADC group is connected to the two baseband low-pass filters, the two baseband low-pass filters are connected to the IQ modulation transmitter, and the IQ modulation transmitter is provided with an antenna; each coil group contains one or more coils, and the maximum number of coils contained in each coil group is determined by available bandwidth, modulation scheme, and the bandwidth, sampling rate, and sampling accuracy of MR signal. The device and corresponding method advantageously allows an increase in the amount of magnetic resonance information transmitted per unit frequency band.

Abstract: Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine are disclosed.

Abstract: Provided are a method and device for storing time series data with adaptive length encoding, including: acquiring data values corresponding to timestamps according to a sequential order of timestamps; using a ratio of storage space values required to pre-store the previous n data values to storage space values required to pre-store rule information of a preset encoding rule and encoding data according to the previous n data values as a storage gain corresponding to the time at which the n-th data value is acquired; storing the rule information of the preset encoding rule and the encoding data corresponding to a previous n?1 data values when the storage gain corresponding to the time at which the n-th data value is acquired is less than that corresponding to the time at which the (n?1)-th data value is acquired.

Abstract: Described herein are methods and devices for treating water, wastewater, and organic wastes. The methods and devices are mixed by using hydraulic surge mixers. This surge mixer is driven by gas and can provide occasional surges of water using large bubbles which are able to move great volume of liquid while minimizing dissolved oxygen transfer to the surrounding liquid. Use of the devices and processes herein provides a simple, eloquent approach to water and wastewater treatment with less operation and maintenance costs than conventional devices and/or processes. The same surge lifting device can also be installed in other reactors to mix the tank content and enhance reaction with reduced energy use and maintenance needs.

Abstract: A columnar storage method and a query method and system for time series data. The storage method includes: dividing a column of time series data into a plurality of pages, wherein each page stores a part of data points of the column of time series data and the sum of the data points stored in all the pages is all the data points in the column of time series data (S1); and setting two parts, i.e., a page header and a page body, for each page, storing summary index information of all the data points in the page in the page header of the page and storing data value information of all the data points in the page in the page body of the page (S2).

Abstract: The invention provides a peptide amide compound represented by the general general formula (I), a preparation method thereof, and a medical application thereof. The compound has a novel structure, better biological activity, and better analgesic effect.

Abstract: A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and memantine or a pharmaceutically acceptable salt of memantine is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.

Abstract: Provided are a capacity expansion method and a capacity expansion system based on a dual-level list structure; a first level list of the dual-level list structure is a first-level array in which at least one array identifier is stored; a second level list of the dual-level list structure includes at least one second-level array, each second-level array stores data to be stored and corresponds to only one array identifier; the method includes: creating a new first-level array when an amount of data stored in the second-level array corresponding to each array identifier reaches a maximum value, a size of a new first-level array being greater than that of a current first-level array, and increasing a number of the second-level arrays; and copying the array identifier stored in the current first-level array to the new first-level array, and replacing the current first-level array with the new first-level array.

Abstract: A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and memantine or a pharmaceutically acceptable salt of memantine is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.

Abstract: Pharmaceutical compositions comprising azelastine or a pharmaceutically acceptable salt of azelastine and alprazolam are disclosed. Methods of using the pharmaceutical compositions for treating perimenopausal or menopausal patients, such as patients suffering from, experiencing, exhibiting and/or having one or more symptoms of anxiety or depression, are also disclosed.

Abstract: Described herein are methods and devices for treating water, wastewater, and organic wastes. The methods and devices are mixed by using hydraulic surge mixers. This surge mixer is driven by gas and can provide occasional surges of water using large bubbles which are able to move great volume of liquid while minimizing dissolved oxygen transfer to the surrounding liquid. Use of the devices and processes herein provides a simple, eloquent approach to water and wastewater treatment with less operation and maintenance costs than conventional devices and/or processes. The same surge lifting device can also be installed in other reactors to mix the tank content and enhance reaction with reduced energy use and maintenance needs.

Abstract: Pharmaceutical compositions containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and alprazolam are disclosed. Methods of using the pharmaceutical compositions for treating patients with Alzheimer's disease for symptoms of depression, anxiety, agitation, delusions, hallucination, irritability and sleeping disorder, are also disclosed.

Abstract: A power supply apparatus for a magnetic resonance apparatus has a power supply terminal module with a power supply unit and a reference voltage pull-down unit, and a load terminal module with a voltage comparator connected to a load power-feed terminal, which compares a nominal voltage and an actual voltage of the load power-feed terminal. A counter begins counting when the actual voltage is lower than the nominal voltage, and keeps its count unchanged when the actual voltage is equal to the nominal voltage, and emits a signal corresponding to the count to a digital-to-analog converter, connected to a phase inverter, which converts the digital signal to a positive analog voltage. A phase inverter is connected to an output voltage reference terminal of the power supply unit, and inverts the phase of the analog voltage to produce a negative analog voltage that compensates voltage drop loss on a cable between the power supply and the load power-feed terminal.

Abstract: Provided are a method and device for storing time series data with adaptive length encoding, including: acquiring data values corresponding to timestamps according to a sequential order of timestamps; using a ratio of storage space values required to pre-store the previous n data values to storage space values required to pre-store rule information of a preset encoding rule and encoding data according to the previous n data values as a storage gain corresponding to the time at which the n-th data value is acquired; storing the rule information of the preset encoding rule and the encoding data corresponding to a previous n?1 data values when the storage gain corresponding to the time at which the n-th data value is acquired is less than that corresponding to the time at which the (n?1)-th data value is acquired.

Abstract: Techniques are disclosed for a local coil and a magnetic resonance imaging system. The local coil includes a plurality of coil units that respectively receive magnetic resonance signals generated when magnetic resonance detection is performed on a detected object, and a signal processing unit configured to perform processing including signal preprocessing and quadrature modulation on the magnetic resonance signals received by the plurality of coil units to obtain signals to be transmitted. Contactless connectors are also disclosed, each being configured to couple the signals to be transmitted to a contactless connector at the MR system side.

Abstract: MR signal transmission line connection structure. A first connector fixed to a bed of an MR imager and connectable to an MR imaging. A second connector, which is disposed at an opposite side of an opening side of a chamber of the MR imaging device allowing entry of the bed, connected to a signal receiver for MR signals by a cable. The first connector has a first connection terminal, and the second connector has a second connection terminal. When the bed moves into the chamber, the first connector abuts the second connector such that the first connection terminal is connected to the second connection terminal, and an MR signal received by the coil is conveyable to the signal receiver via the first and second connection terminals. When the MR imaging ends, the bed moves back out of the chamber, breaking the connection between the first and second connection terminals.

Abstract: Pharmaceutical compositions comprising azelastine or a pharmaceutically acceptable salt of azelastine and alprazolam are disclosed. Methods of using the pharmaceutical compositions for treating patients suffering from one or more psychiatric disorders such as major depressive disorder, generalized anxiety disorder, panic disorder, agitation, social anxiety disorder, mild chronic depression, obsessive-compulsive disorder, premenstrual dysphoric disorder, seasonal affective disorder, dysthymia, childhood enuresis, bipolar disorder, posttraumatic stress disorder, sleep disorder related to anxiety, are also disclosed.

Abstract: A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and memantine or a pharmaceutically acceptable salt of memantine is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.

Abstract: A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and memantine or a pharmaceutically acceptable salt of memantine is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.